AAOS.org is currently experiencing longer than usual load times when logging in. We are working to correct this issue and hope to resolve it shortly. We apologize for the inconvenience and thank you for your patience.
AAOS Now / Issue
Ryan Pezold, MA
The use of MSC injections as regenerative therapy continues to grow as an area of acute interest for many clinicians and patients, despite a lack of high-quality evidence suggesting clinical efficacy.
Some AAOS Now articles are available only to AAOS members. Please log in to access this article.
Not a member? Become a member.